assess-demographic-covariate-effectslisted

# Demographic Covariate Effects Assessment Assess the characterisation of age, sex and body-size covariate effects on drug exposure across a programme's evidence base — population PK covariate analyses, dedicated sub-studies, the factor-coverage matrix and the labelling concept — producing a reconciled register in which every stated effect carries its source and every source-identified effect carries its downstream statement. **This skill assesses characterisation completeness and traceability. It never decides that a covariate effect is clinically meaningful, selects or adjusts a dose, or determines that characterisation is sufficient for filing.** ## Who this is for Clinical pharmacology leads checking that demographic covariate effects are characterised and internally consistent before a submission · CP reviewers verifying that every demographic statement in the label traces to the PopPK or a dedicated study · regulatory writers who need each demographic claim source-linked. ## When to use this skill - "Are age, weight and sex effects characterised for this compound?" - "Does the PopPK covariate analysis cover all the demographic effects the label claims?" - "Which demographic covariates are still uncharacterised before we file?" - "Do the age and body-size statements in Section 8 match the PopPK report?" - "Reconcile the demographic covariate effects across the PopPK, CSR and 2.7.2" ## When NOT to use this skill These are close neighbours. Route them elsewhere and